160 related articles for article (PubMed ID: 20164855)
1. Generation of multi-functional antigen-specific human T-cells by lentiviral TCR gene transfer.
Perro M; Tsang J; Xue SA; Escors D; Cesco-Gaspere M; Pospori C; Gao L; Hart D; Collins M; Stauss H; Morris EC
Gene Ther; 2010 Jun; 17(6):721-32. PubMed ID: 20164855
[TBL] [Abstract][Full Text] [Related]
2. Influenza virus-specific TCR-transduced T cells as a model for adoptive immunotherapy.
Berdien B; Reinhard H; Meyer S; Spöck S; Kröger N; Atanackovic D; Fehse B
Hum Vaccin Immunother; 2013 Jun; 9(6):1205-16. PubMed ID: 23428899
[TBL] [Abstract][Full Text] [Related]
3. T cell receptor (TCR) gene transfer with lentiviral vectors allows efficient redirection of tumor specificity in naive and memory T cells without prior stimulation of endogenous TCR.
Circosta P; Granziero L; Follenzi A; Vigna E; Stella S; Vallario A; Elia AR; Gammaitoni L; Vitaggio K; Orso F; Geuna M; Sangiolo D; Todorovic M; Giachino C; Cignetti A
Hum Gene Ther; 2009 Dec; 20(12):1576-88. PubMed ID: 19678763
[TBL] [Abstract][Full Text] [Related]
4. Enhancing lentiviral transduction to generate melanoma-specific human T cells for cancer immunotherapy.
Simon B; Harrer DC; Thirion C; Schuler-Thurner B; Schuler G; Uslu U
J Immunol Methods; 2019 Sep; 472():55-64. PubMed ID: 31207210
[TBL] [Abstract][Full Text] [Related]
5. Identification of chimeric antigen receptors that mediate constitutive or inducible proliferation of T cells.
Frigault MJ; Lee J; Basil MC; Carpenito C; Motohashi S; Scholler J; Kawalekar OU; Guedan S; McGettigan SE; Posey AD; Ang S; Cooper LJ; Platt JM; Johnson FB; Paulos CM; Zhao Y; Kalos M; Milone MC; June CH
Cancer Immunol Res; 2015 Apr; 3(4):356-67. PubMed ID: 25600436
[TBL] [Abstract][Full Text] [Related]
6. TCR gene-engineered T cell: limited T cell activation and combined use of IL-15 and IL-21 ensure minimal differentiation and maximal antigen-specificity.
Pouw N; Treffers-Westerlaken E; Mondino A; Lamers C; Debets R
Mol Immunol; 2010 Apr; 47(7-8):1411-20. PubMed ID: 20303179
[TBL] [Abstract][Full Text] [Related]
7. Isolation and Characterization of an HLA-DRB1*04-Restricted HPV16-E7 T Cell Receptor for Cancer Immunotherapy.
Mercier-Letondal P; Marton C; Deschamps M; Ferrand C; Vauchy C; Chenut C; Baguet A; Adotévi O; Borg C; Galaine J; Godet Y
Hum Gene Ther; 2018 Oct; 29(10):1202-1212. PubMed ID: 30136612
[TBL] [Abstract][Full Text] [Related]
8. Molecular immunology lessons from therapeutic T-cell receptor gene transfer.
Thomas S; Stauss HJ; Morris EC
Immunology; 2010 Feb; 129(2):170-7. PubMed ID: 20561357
[TBL] [Abstract][Full Text] [Related]
9. A simplified method for the clinical-scale generation of central memory-like CD8+ T cells after transduction with lentiviral vectors encoding antitumor antigen T-cell receptors.
Yang S; Dudley ME; Rosenberg SA; Morgan RA
J Immunother; 2010; 33(6):648-58. PubMed ID: 20551831
[TBL] [Abstract][Full Text] [Related]
10. Human effector T cells derived from central memory cells rather than CD8(+)T cells modified by tumor-specific TCR gene transfer possess superior traits for adoptive immunotherapy.
Wu F; Zhang W; Shao H; Bo H; Shen H; Li J; Liu Y; Wang T; Ma W; Huang S
Cancer Lett; 2013 Oct; 339(2):195-207. PubMed ID: 23791878
[TBL] [Abstract][Full Text] [Related]
11. Optimization of lentiviral vector transduction into peripheral blood mononuclear cells in combination with the fibronectin fragment CH-296 stimulation.
Chono H; Goto Y; Yamakawa S; Tanaka S; Tosaka Y; Nukaya I; Mineno J
J Biochem; 2011 Mar; 149(3):285-92. PubMed ID: 21106541
[TBL] [Abstract][Full Text] [Related]
12. Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer.
Provasi E; Genovese P; Lombardo A; Magnani Z; Liu PQ; Reik A; Chu V; Paschon DE; Zhang L; Kuball J; Camisa B; Bondanza A; Casorati G; Ponzoni M; Ciceri F; Bordignon C; Greenberg PD; Holmes MC; Gregory PD; Naldini L; Bonini C
Nat Med; 2012 May; 18(5):807-815. PubMed ID: 22466705
[TBL] [Abstract][Full Text] [Related]
13. T cell receptor-engineered T cells to treat solid tumors: T cell processing toward optimal T cell fitness.
Lamers CH; van Steenbergen-Langeveld S; van Brakel M; Groot-van Ruijven CM; van Elzakker PM; van Krimpen B; Sleijfer S; Debets R
Hum Gene Ther Methods; 2014 Dec; 25(6):345-57. PubMed ID: 25423330
[TBL] [Abstract][Full Text] [Related]
14. Generation of human islet-specific regulatory T cells by TCR gene transfer.
Hull CM; Nickolay LE; Estorninho M; Richardson MW; Riley JL; Peakman M; Maher J; Tree TI
J Autoimmun; 2017 May; 79():63-73. PubMed ID: 28117148
[TBL] [Abstract][Full Text] [Related]
15. Cooperative Armoring of CAR and TCR T Cells by T Cell-Restricted IL15 and IL21 Universally Enhances Solid Tumor Efficacy.
Nguyen R; Doubrovina E; Mousset CM; Jin BY; Okada R; Zhang X; Clavel A; Reyes-Gonzalez JM; Dyomin V; Diaz L; Zhang L; Abbas S; Sun M; Hsieh CM; Ho M; Shern JF; Gulley JL; Hinrichs CS
Clin Cancer Res; 2024 Apr; 30(8):1555-1566. PubMed ID: 37910044
[TBL] [Abstract][Full Text] [Related]
16. Lentiviral vector gene transfer into human T cells.
Verhoeyen E; Costa C; Cosset FL
Methods Mol Biol; 2009; 506():97-114. PubMed ID: 19110622
[TBL] [Abstract][Full Text] [Related]
17. T-cell receptor gene transfer by lentiviral vectors in adoptive cell therapy.
Bobisse S; Zanovello P; Rosato A
Expert Opin Biol Ther; 2007 Jun; 7(6):893-906. PubMed ID: 17555374
[TBL] [Abstract][Full Text] [Related]
18. T cell re-targeting to EBV antigens following TCR gene transfer: CD28-containing receptors mediate enhanced antigen-specific IFNgamma production.
Schaft N; Lankiewicz B; Drexhage J; Berrevoets C; Moss DJ; Levitsky V; Bonneville M; Lee SP; McMichael AJ; Gratama JW; Bolhuis RL; Willemsen R; Debets R
Int Immunol; 2006 Apr; 18(4):591-601. PubMed ID: 16507598
[TBL] [Abstract][Full Text] [Related]
19. Human T lymphocytes transduced by lentiviral vectors in the absence of TCR activation maintain an intact immune competence.
Cavalieri S; Cazzaniga S; Geuna M; Magnani Z; Bordignon C; Naldini L; Bonini C
Blood; 2003 Jul; 102(2):497-505. PubMed ID: 12649146
[TBL] [Abstract][Full Text] [Related]
20. In vivo programming of tumor antigen-specific T lymphocytes from pluripotent stem cells to promote cancer immunosurveillance.
Lei F; Zhao B; Haque R; Xiong X; Budgeon L; Christensen ND; Wu Y; Song J
Cancer Res; 2011 Jul; 71(14):4742-7. PubMed ID: 21628492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
